Evaluate the Pharmacokinetics of BAT2022 in Healthy Chinese Subjects
NCT05518695
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
SARS-CoV-2 Infection
Interventions
DRUG:
BAT2022
Sponsor
Bio-Thera Solutions